Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders

Author： Croom Katherine F.   McCormack Paul L.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.22, Iss.2, 2008-01, pp. : 121-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octocog Alfa (Advate®): A Guide to Its Use in Hemophilia A

By Keating Gillian M.   Dhillon Sohita  

BioDrugs, Vol. 26, Iss. 4, 2012-08 ,pp. : 269-273

Adis International

Access to resources Recommend Favorite

Italian Registry of Congenital Bleeding Disorders

By Giampaolo Adele   Abbonizio Francesca   Arcieri Romano   Hassan Hamisa Jane  

Journal of Clinical Medicine, Vol. 6, Iss. 3, 2017-03 ,pp. : 34-34

MDPI

Access to resources Recommend Favorite

Recombinant Factor VIIa

By Dunn C.J.   Spencer C.M.  

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 71-77

Adis International

Access to resources Recommend Favorite

Recombinant Factor VIIa: A Viewpoint by Amy D. Shapiro

By Shapiro A.D.  

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 78-79

Adis International

Access to resources Recommend Favorite

Agalsidase Alfa: A Review of its Use in the Management of Fabry Disease

By Keating Gillian M.  

BioDrugs, Vol. 26, Iss. 5, 2012-10 ,pp. : 335-354

Adis International

Access to resources Recommend Favorite